New England Biolabs® and Color Partner to Provide COVID-19 Testing to Biotech Workers Essential to Global Pandemic Response
Regularly testing New England Biolabs employees helps maintain the supply of enzymes for crucial scientific research, including developing COVID-19 vaccines.
IPSWICH, Mass. and SAN FRANCISCO, Feb. 2, 2021 /PRNewswire/ -- Today, biotech manufacturer and supplier New England Biolabs (NEB®) and Color, a leading health technology company committed to advancing public health, announced their partnership providing weekly COVID-19 testing to NEB's US-based employees. This partnership enables NEB employees to continue their essential role in manufacturing critical materials necessary for the development of COVID-19 diagnostic tests and vaccines.
NEB supplies enzymes used in scientific research and development at universities, academic medical centers, biotech, diagnostic and pharmaceutical companies. Many NEB products are currently used in laboratories researching the SARS-CoV-2 virus by scientists developing and performing COVID-19 diagnostic tests and by researchers working on vaccines.
"Our number one priority is to ensure the safety of our staff and our business continuity," said Jim Ellard, CEO of New England Biolabs. "Color's testing program helps us protect our employees, ensuring our ability to meet the high demand for enzymes necessary for basic research, cutting-edge discoveries and, ultimately, the diagnostics and vaccines that will stop the spread of the SARS-CoV-2 virus."
During the pandemic, demand for NEB products has increased, and the company has added new infrastructure and hired new people to meet this demand. To keep employees safe while growing, NEB has implemented a comprehensive mitigation strategy to prevent an outbreak that includes wearing masks, social distancing, carefully scheduling shifts, enabling remote work, and weekly COVID-19 tests, provided by Color. Since September, over 400 employees have submitted test samples, initially bi-weekly and now weekly through Color's platform.
Color's platform, which uses NEB's Colorimetric LAMP reagents, makes it easy for NEB to provide fast, accurate testing to all employees who work at NEB's headquarters. Employees use Color's testing kit to self-collect samples, which are then dropped off in a designated location. The kits are mailed to Color's lab and 97% of test results are returned within 24 hours, with a median turnaround time of 11 hours.
"We have found a partner in New England Biolabs who shares our mission to improve public health," said Color CEO Othman Laraki. "Both biotech research and improved access to testing will help us win the fight against COVID-19. We are grateful for the opportunity to partner with NEB and support employees to continue their important work."
Since April, Color has become a leader in responding to the in COVID-19 pandemic, working with states, cities, universities, and employers to increase access to fast, convenient, and reliable testing. To date, Color has returned more than 2 million COVID-19 test results to partners across the nation, including state and local governments, universities, and businesses.
About Color
Color is a leader in distributed healthcare and clinical testing. Color makes population-scale healthcare programs accessible, convenient, and cost-effective for everyone. Color works with health systems, employers, and national health initiatives around the world including the million-person All of Us Research Program by the National Institutes of Health. For more information about Color and its response to COVID-19, visit www.color.com.
About New England Biolabs
Established in the mid 1970's, New England Biolabs, Inc. (NEB) is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including molecular diagnostics development. New England Biolabs is a privately held company, headquartered in Ipswich, MA, and has extensive worldwide distribution through a network of exclusive distributors, agents and eight subsidiaries located in Australia, Canada, China, France, Germany, Japan, Singapore and the UK. For more information about New England Biolabs, visit www.neb.com.
CONTACT: Deana D. Martin, Ph.D., Associate Director, Marketing Communications, New England Biolabs, 240 County Road Ipswich, MA 01938, Tel: 978-380-7464, Email: martin@neb.com
